Halozyme Therapeutics, Inc. Q2 adjusted earnings Beat Estimates

(RTTNews) - Halozyme Therapeutics, Inc. (HALO) released a profit for its second quarter that advanced from last year.

The company's profit came in at $91.5 million, or $0.62 per share. This compares with $25.8 million, or $0.19 per share, in last year's second quarter.

Excluding items, Halozyme Therapeutics, Inc. reported adjusted earnings of $97.8 million or $0.66 per share for the period.

Analysts had expected the company to earn $0.40 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 147.3% to $136.5 million from $55.2 million last year.

Halozyme Therapeutics, Inc. earnings at a glance:

-Earnings (Q2): $97.8 Mln. vs. $33.6 Mln. last year. -EPS (Q2): $0.66 vs. $0.24 last year. -Analysts Estimate: $0.40 -Revenue (Q2): $136.5 Mln vs. $55.2 Mln last year.

-Guidance: Full year EPS guidance: $1.85-$2.00 Full year revenue guidance: $425-445 mln